Presenter: Christopher Gould, PhD Technical Applications Scientist, BioLegend
In recent years, the involvement of immune cells in controlling cancers has come to the forefront of therapy and research. It is now evident that immune cells are central to the three “E’s” of cancer immunoediting: Elimination, Equilibrium, and Escape, as tumors devise a diverse set of mechanisms to overcome immune control. One critical mechanism is the expression of...
Guest speaker: Jurgen Knoblich, PhD Deputy Director and Senior Scientist Institute of Molecular Biotechnology of the Austrian Academy of Sciences, (IMBA) Adjunct Professor, Medical University of Vienna